Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03060720
Recruitment Status : Active, not recruiting
First Posted : February 23, 2017
Last Update Posted : March 22, 2021
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Matthew B. Yurgelun, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : April 7, 2019
Estimated Study Completion Date : February 2022